المؤلفون: de Oliveira Ferreira C; Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil., Carneiro VCG; Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.; Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco, Brazil., Araujo Mariz C; Instituto Aggeu Magalhães, FIOCRUZ, Recife, Pernambuco, Brazil. carolline.mariz@fiocruz.br.; Faculdade de Medicina de Olinda, Olinda, Pernambuco, Brazil. carolline.mariz@fiocruz.br.

المصدر: BMC cancer [BMC Cancer] 2024 Apr 19; Vol. 24 (1), pp. 499. Date of Electronic Publication: 2024 Apr 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , Ovarian Neoplasms*/epidemiology , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology, Humans ; Female ; Brazil/epidemiology ; Germ-Line Mutation ; Cross-Sectional Studies ; Public Health ; Genetic Predisposition to Disease ; BRCA2 Protein/genetics ; BRCA1 Protein/genetics

المؤلفون: Narod SA; Women's College Research Institute, Toronto, Ontario, Canada.

المصدر: JAMA [JAMA] 2024 Apr 09; Vol. 331 (14), pp. 1233-1234.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Breast Neoplasms*/surgery , Genes, BRCA1* , Genes, BRCA2* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality , Pregnancy Complications, Neoplastic*/surgery, Female ; Humans ; Pregnancy ; Age Factors ; Heterozygote ; Survival Analysis

المؤلفون: Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy.

المصدر: JAMA [JAMA] 2024 Apr 09; Vol. 331 (14), pp. 1234.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Breast Neoplasms*/surgery , Genes, BRCA2* , Genes, BRCA1* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality , Pregnancy Complications, Neoplastic*/surgery, Female ; Humans ; Pregnancy ; Heterozygote ; Ovariectomy ; Salpingectomy ; Adult ; Middle Aged ; Survival Analysis ; Time Factors ; Risk

المؤلفون: De Matteis E; U.O.S.V.D. Oncological Screenings, 'Vito Fazzi' Hospital, Lecce, Italy., Tumolo MR; Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy., Tarantino P; U.O.C. Medical Genetics, 'Vito Fazzi' Hospital, Lecce, Italy., Ciccarese M; Strategic Regional Agency for Health and Social of Puglia, Bari, Italy., Grassi T; Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy., Bagordo F; Department of Pharmacy-Pharmaceutical Sciences, University of Bari 'Aldo Moro', Bari, Italy., De Giorgio MR; U.O.S.V.D. Oncological Screenings, 'Vito Fazzi' Hospital, Lecce, Italy., Rizzo E; Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy., Ronzino G; Oncology Unit, 'Vito Fazzi' Hospital, Lecce, Italy.

المصدر: Oncotarget [Oncotarget] 2024 Feb 22; Vol. 15, pp. 134-141. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , Ovarian Neoplasms*/epidemiology , Ovarian Neoplasms*/genetics, Female ; Humans ; Middle Aged ; BRCA2 Protein/genetics ; Prevalence ; BRCA1 Protein/genetics ; Preventive Health Services ; Italy/epidemiology ; Germ Cells

المؤلفون: Barili V; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Ambrosini E; Medical Genetics, University Hospital of Parma, 43126 Parma, Italy., Bortesi B; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Minari R; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., De Sensi E; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Cannizzaro IR; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Taiani A; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Michiara M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Sikokis A; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Boggiani D; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Tommasi C; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Serra O; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Bonatti F; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Adorni A; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Luberto A; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Caggiati P; Medical Genetics, University Hospital of Parma, 43126 Parma, Italy., Martorana D; Medical Genetics, University Hospital of Parma, 43126 Parma, Italy., Uliana V; Medical Genetics, University Hospital of Parma, 43126 Parma, Italy., Percesepe A; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Medical Genetics, University Hospital of Parma, 43126 Parma, Italy., Musolino A; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy., Pellegrino B; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Breast Unit, University Hospital of Parma, 43126 Parma, Italy.

المصدر: Genes [Genes (Basel)] 2024 Feb 08; Vol. 15 (2). Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , Ovarian Neoplasms*/pathology, Female ; Humans ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Recombinational DNA Repair ; DNA Breaks, Double-Stranded ; Poly(ADP-ribose) Polymerases/genetics

المؤلفون: Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Agostinetto E; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Hilbers F; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Moore HCF; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France., Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy., Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Del Pilar Estevez-Diz M; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rodriguez-Wallberg KA; Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden.; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Mrinakova B; First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia., Meister S; Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany., Livraghi L; Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Yerushalmi R; Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel., De Angelis C; Department of Medical Oncology, University of Naples Federico II, Napoli, Italy., Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Meattini I; Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy., Cichowska-Cwalinska N; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Early Phase Clinical Trials Centre, Medical University of Gdańsk, Gdańsk, Poland., Berlière M; Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Belgium., Salama M; Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy., Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chiodi C; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lee YJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Maria C; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Cairo Oncology Center, Cairo, Egypt., Boni L; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

مؤلفون مشاركون: BRCA BCY Collaboration

المصدر: JAMA [JAMA] 2024 Jan 02; Vol. 331 (1), pp. 49-59.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Genes, BRCA2* , Genes, BRCA1* , Pregnancy Outcome* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality, Adult ; Female ; Humans ; Pregnancy ; Disease-Free Survival ; Germ-Line Mutation ; Retrospective Studies ; Internationality

المؤلفون: Krais JJ; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. krais@wustl.edu.; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA. krais@wustl.edu., Glass DJ; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.; Temple University, Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA., Chudoba I; MetaSystems Probes, GmbH, Industriestr, 68804, Altlussheim, Germany., Wang Y; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Feng W; Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27599, USA., Simpson D; Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27599, USA., Patel P; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Liu Z; Cytogenetics Laboratory, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Neumann-Domer R; Cytogenetics Laboratory, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Betsch RG; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Bernhardy AJ; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Bradbury AM; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Conger J; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Yueh WT; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Nacson J; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Pomerantz RT; Thomas Jefferson University, Sidney Kimmel Cancer Center, Department of Biochemistry and Molecular Biology, Philadelphia, PA, 19107, USA., Gupta GP; Cancer Control and Prevention Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Testa JR; Cytogenetics Laboratory, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.; Cancer Control and Prevention Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA., Johnson N; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. neil.johnson@fccc.edu.

المصدر: Nature communications [Nat Commun] 2023 Nov 24; Vol. 14 (1), pp. 7714. Date of Electronic Publication: 2023 Nov 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein*/genetics , Genes, BRCA2*, Mice ; Animals ; Humans ; Mutation ; Synthetic Lethal Mutations ; DNA

المؤلفون: Biswas K; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Mitrophanov AY; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Sahu S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Sullivan T; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Southon E; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA; Leidos Biomed Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Nousome D; Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Reid S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Narula S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Smolen J; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Sengupta T; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Riedel-Topper M; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Kapoor M; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Babbar A; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Stauffer S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Cleveland L; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Tandon M; Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Malys T; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA. Electronic address: sharans@mail.nih.gov.

المصدر: Cell reports methods [Cell Rep Methods] 2023 Nov 20; Vol. 3 (11), pp. 100628. Date of Electronic Publication: 2023 Nov 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2667-2375 (Electronic) Linking ISSN: 26672375 NLM ISO Abbreviation: Cell Rep Methods Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , Ovarian Neoplasms*/genetics, Humans ; Female ; Male ; Animals ; Mice ; Mouse Embryonic Stem Cells ; BRCA2 Protein/genetics

المؤلفون: Marchetti C; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy., Ataseven B; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., Perrone AM; Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Cassani C; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy., Fruscio R; Department of Medicine and Surgery, University of Milan - Bicocca, Italy., Sassu CM; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy., Apostol AI; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy., Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., De Iaco P; Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Camnasio CA; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy., Moubarak M; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Nordrhein-Westfalen, Germany., Giannarelli D; Facility of Epidemiology and Biostatistics - GSTeP, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Scambia G; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: giovanni.scambia@policlinicogemelli.it., Fagotti A; Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 170-177. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/mortality , Ovarian Neoplasms*/therapy , Mutation* , Neoplasm Staging* , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/mortality , Cystadenocarcinoma, Serous*/therapy, Humans ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; BRCA1 Protein/genetics ; Neoplasm Grading ; Aged, 80 and over ; BRCA2 Protein/genetics ; Genes, BRCA1 ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Genes, BRCA2 ; Progression-Free Survival ; Prognosis

المؤلفون: Franco S; Department of Medicine, Northwestern Medicine, Chicago, IL 60611, United States of America., Godley LA; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America. Electronic address: lucy.godley@northwestern.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 235-240. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , Ovarian Neoplasms*/genetics , Breast Neoplasms*/genetics , Genetic Predisposition to Disease*, Humans ; Female ; Neoplasms, Second Primary/genetics ; Neoplasms, Second Primary/epidemiology ; Ataxia Telangiectasia Mutated Proteins/genetics ; Checkpoint Kinase 2/genetics ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Hematologic Neoplasms/genetics ; Genes, BRCA2 ; Fanconi Anemia Complementation Group N Protein